Cargando…
Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions
The most effective treatment for HIV-1, antiretroviral therapy, suppresses viral replication and averts the disease from progression. Nonetheless, there is a need for alternative treatments as it requires daily administration with the possibility of side effects and occurrence of drug resistance. Br...
Autores principales: | Schriek, Angela I., van Haaren, Marlies M., Poniman, Meliawati, Dekkers, Gillian, Bentlage, Arthur E. H., Grobben, Marloes, Vidarsson, Gestur, Sanders, Rogier W., Verrips, Theo, Geijtenbeek, Teunis B. H., Heukers, Raimond, Kootstra, Neeltje A., de Taeye, Steven W., van Gils, Marit J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150821/ https://www.ncbi.nlm.nih.gov/pubmed/35651621 http://dx.doi.org/10.3389/fimmu.2022.893648 |
Ejemplares similares
-
Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions
por: Schriek, Angela I., et al.
Publicado: (2022) -
Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses
por: Radić, Laura, et al.
Publicado: (2023) -
IgG Glyco-Engineering to Improve IVIg Potency
por: Bruggeman, Christine W., et al.
Publicado: (2018) -
The Ligands for Human IgG and Their Effector Functions
por: de Taeye, Steven W., et al.
Publicado: (2019) -
A SARS-CoV-2 Wuhan spike virosome vaccine induces superior neutralization breadth compared to one using the Beta spike
por: van der Velden, Yme U., et al.
Publicado: (2022)